The Role of Rho Kinase Inhibitors in Corneal Diseases
Stefan Futterknecht,1,2 Eleftherios Chatzimichail,1 Konstantin Gugleta,1,3 Georgios D Panos,4,5,* Zisis Gatzioufas1,3,* 1Department of Ophthalmology, University Hospital of Basel, Basel, Switzerland; 2Institute of Molecular and Clinical Ophthalmology Basel, Basel, Switzerland; 3Depar...
Saved in:
Main Authors: | Futterknecht S (Author), Chatzimichail E (Author), Gugleta K (Author), Panos GD (Author), Gatzioufas Z (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?
by: Chatzimichail E, et al.
Published: (2024) -
Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma
by: Al-Humimat G, et al.
Published: (2021) -
Antivasospastic Effects of Hydroxyfasudil, a Rho-Kinase Inhibitor, After Subarachnoid Hemorrhage
by: Shin-ichi Satoh, et al.
Published: (2012) -
Alleviating Effects of AS1892802, a Rho Kinase Inhibitor, on Osteoarthritic Disorders in Rodents
by: Nobuaki Takeshita, et al.
Published: (2011) -
Mechanical stress regulates gene expression via Rho/Rho-kinase signaling pathway
by: Takako Kaneko-Kawano, et al.
Published: (2015)